glp 1 with hormone therapy UC Davis Health examines systemic impact of GLP-1–based therapies GLP- 1 Agonist Therapy Center

Oral health is significantly linked to the risk of developing chronic conditions such as cognitive decline, type 2 diabetes, cardiovascular diseases, various cancers, and heart disease

In addition, animal, observational, and genetic studies suggest benefits of GLP-1RAs in people with alcohol use disorder, although randomized trials have produced mixed results, with ongoing trials assessing their effectiveness in those with substance use disorders (SUDs) and mental illnesses

Key Takeaways GLP-1 medications are associated with a higher risk of gallstones and gallbladder disease, and FDA labeling for Zepbound and Wegovy lists gallstones and acute cholecystitis as possible risks

So if you can maybe substitute lobster instead of crab, I think that's what that means

Montalban-Bravo G, Benton CB, Kanagal-Shamanna R, Sasaki K, Assi R, Kadia TM, Ravandi F, Ganan-Gomez I, Cortes JE, Daver NG, Takahashi K, DiNardo CD, Jabbour EJ, Borthakur G, Pemmaraju N, Konopleva MY, Pierce SA, Bueso-Ramos CE, Kornblau SM, Patel K, Colla S, Kantarjian HM, Andreeff MA, Garcia-Manero G

HIMS had been getting away with selling compounded injectable semaglutide in a post-shortage regulatory environment for over a year, largely uncontested